515 A phase 1 study of myeloid modulating agent MTL-CEBPA in combination with pembrolizumab in adult patients with advanced solid tumours
oleh: Ruth Plummer, Alessio Cortellini, Debashis Sarker, Ilian Tchakov, John Rossi, David Pinato, Mikael Sodergren, Vikash Reebye, Duncan Spalding, Nina Raulf, Laura Sinigaglia, Thomas Talbot, Antonio D’Alessio, Robert Habib, Nagy Habib
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.